Literature DB >> 19553358

A comparison of four tests of cognition as predictors of inability to perform spirometry in old age.

Stephen C Allen1, Mark Baxter.   

Abstract

BACKGROUND: previous studies have shown that a Mini Mental State Examination (MMSE) score of <24/30 and inability to copy intersecting pentagons (IP) predicts inability to perform spirometry. We hypothesised that clock drawing tests (CLOX 1 and 2), being validated tests of cognitive executive function, might predict spirometry performance with a higher sensitivity and specificity than the MMSE or IP.
METHODS: we studied 113 (84 females) spirometry-naïve inpatients, mean age of 84 years (range 74-97). All performed the MMSE, IP, CLOX 1 and 2 and then attempted to perform assisted spirometry to the American Thoracic Society/European Respiratory Society standard.
RESULTS: of 113, 49 met the criteria for adequate spirometry. Using normative thresholds for probable impairment, inability to perform spirometry was predicted by MMSE <24/30 with a sensitivity of 81% and specificity of 90% (P<0.0000); by inability to copy IP with a sensitivity of 92% and specificity of 100% (P<0.0000); by CLOX1 <10/15 with a sensitivity of 81% and specificity of 49% (P<0.001); and by CLOX2 <12/15 with a sensitivity of 63% and specificity of 65% (P<0.001).
CONCLUSION: CLOX tests did not perform better than MMSE and IP to identify subjects unlikely to be able to perform spirometry. Achieving assisted spirometry from the naïve state in old age might be more determined by global cognitive function and ideo-motor praxis than by executive control function.

Entities:  

Mesh:

Year:  2009        PMID: 19553358     DOI: 10.1093/ageing/afp104

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  12 in total

Review 1.  Optimizing Drug Therapies in Patients with COPD in the US Nursing Home Setting.

Authors:  Roy A Pleasants; Peter A Radlowski; H Edward Davidson
Journal:  Drugs Aging       Date:  2019-08       Impact factor: 3.923

Review 2.  Leukotriene Receptor Antagonists for the Treatment of Asthma in Elderly Patients.

Authors:  Hoang Kim Tu Trinh; Ga-Young Ban; Ji-Ho Lee; Hae-Sim Park
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

3.  Resting respiration rate predicts all-cause mortality in older outpatients.

Authors:  Atsushi Takayama; Taro Takeshima; Hajime Yamazaki; Tsukasa Kamitani; Sayaka Shimizu; Shunichi Fukuhara; Yosuke Yamamoto
Journal:  Aging Clin Exp Res       Date:  2022-04-26       Impact factor: 3.636

4.  [Lung function test in advanced age].

Authors:  Helmut Frohnhofen; Jeanina Schlitzer; Sven Stieglitz
Journal:  Z Gerontol Geriatr       Date:  2022-09-15       Impact factor: 1.292

5.  Predictors of poor-quality spirometry in two cohorts of older adults in Russia and Belgium: a cross-sectional study.

Authors:  Eralda Turkeshi; Dmitry Zelenukha; Bert Vaes; Elena Andreeva; Elena Frolova; Jean-Marie Degryse
Journal:  NPJ Prim Care Respir Med       Date:  2015-07-23       Impact factor: 2.871

6.  Acceptable alternatives for forced vital capacity in the spirometric diagnosis of bronchial asthma.

Authors:  Mohamed Faisal Lutfi
Journal:  Int J Appl Basic Med Res       Date:  2011-01

Review 7.  Considerations for managing chronic obstructive pulmonary disease in the elderly.

Authors:  George E Taffet; James F Donohue; Pablo R Altman
Journal:  Clin Interv Aging       Date:  2013-12-13       Impact factor: 4.458

Review 8.  Asthma in the elderly: a different disease?

Authors:  Salvatore Battaglia; Alida Benfante; Mario Spatafora; Nicola Scichilone
Journal:  Breathe (Sheff)       Date:  2016-03

9.  Age and mini-mental state examination score can predict poor-quality spirometry in the elderly: a cross-sectional study.

Authors:  Rodrigo Santos de Queiroz; Luciano Magno de Almeida Faria; José Ailton Oliveira Carneiro; Raildo da Silva Coqueiro; Marcos Henrique Fernandes
Journal:  Clinics (Sao Paulo)       Date:  2018-10-08       Impact factor: 2.365

Review 10.  Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Possible Utility of Marine Bioactive Compounds.

Authors:  Giulia Prinzi; Alessia Santoro; Palma Lamonaca; Vittorio Cardaci; Massimo Fini; Patrizia Russo
Journal:  Mar Drugs       Date:  2018-09-04       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.